We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Glycosylated Hemoglobin as a Diagnostic Test for Type 2 Diabetes Mellitus

Mayer B. Davidson, MD; David L. Schriger, MD; Anne L. Peters, MD; Brett Lorber, MPH
JAMA. 2000;283(5):605-607. doi:10.1001/jama.283.5.601.
Text Size: A A A
Published online


To the Editor: In our article1 we advised against diagnosing diabetes mellitus in individuals with normal or only slightly elevated HbA1C levels. However, we take issue with several points raised in the editorial by Dr Vinicor2 that accompanied our article.

We agree with Vinicor that there will be both false-positive and false-negative results using our alternative approach to the diagnosis of diabetes. Regarding false-positives, Vinicor cites the 2.8% prevalence of increased HbA1C levels in NHANES III subjects with normal FPG concentrations. However, by definition, 2.5% of a normal population will have values 2 SDs above the normal range. Only 0.1% had an HbA1C level exceeding 1% above the upper limit of normal. This level was selected as diagnostic because 4 studies showed almost no development or progression of retinopathy or microalbuminuria over 6 to 10 years in patients with either type 13,4 or type 25,6 diabetes with lower values. If our alternative approach to the diagnosis of diabetes had been used to characterize the NHANES III population, neither false-positive nor false-negative diagnoses would have occurred because HbA1C levels would not have been measured in subjects with normal FPG values or those of 7.8 mmol/L (140 mg/dL) or more.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.